YOLFTbeta
Biome Australia Ltd

Biome Australia Ltd

BIO · AU · Consumer Defensive / Packaged Foods

0.37AUD-0.01 (-2.63%)

Price History

Full chart

Market Stats

Previous Close0.38
Open0.38
Day Range0.365 – 0.38
52-Week Range0.20 – 0.51
Volume101.17K
Market Cap97.19M
P/E (TTM)21.00
Forward P/E0.00
EPS0.02
Dividend Yield0.00%
Beta0.99
50-Day Avg0.3328
200-Day Avg0.3411

About

Biome Australia Limited engages in the development, commercialization, and marketing of live biotherapeutics and complementary medicines in Australia and internationally. It provides its products under the Activated Probiotics and Activated Therapeutics brand names. The company's products are used to support the management of low mood and sleep, bone health, iron malabsorption, mild eczema, and IBS. It markets its products through community pharmacies, independent health practitioners, and health professionals. The company was incorporated in 2018 and is based in Collingwood, Australia.

Company Details

  • SectorConsumer Defensive
  • IndustryPackaged Foods
  • CEOMr. Blair William Brabin Vega Norfolk
  • Employees0
  • Headquarters192-194 Johnston Street, Collingwood, VIC, Australia, 3066, Australia
  • Websitehttps://www.biomeaustralia.com

Leadership

  • Mr. Blair William Brabin Vega NorfolkMD, CEO & Director · b. 1986
  • Ms. Lauren DwyerChief Financial Officer
  • Dr. Jaroslav Haman BoublikChief Science Officer & Member of Scientific Advisory Board
  • Mr. George Lazarou ACA, BComCompany Secretary

Financials

Income Statement

Currency: AUD2019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue386.60K866.14K2.32M4.11M7.24M13.01M18.42M23.88M
Growth (%)-+124.04%+167.67%+77.40%+75.92%+79.79%+41.57%+29.68%
Cost of Revenue165.11K634.92K1.25M1.74M3.18M5.10M7.16M17.14M
Gross Profit221.49K231.21K1.07M2.38M4.06M7.91M11.26M6.74M
Gross Margin57.29%26.69%46.23%57.81%56.04%60.81%61.12%28.22%
Operating Expense2.12M2.84M6.60M6.59M7.33M9.58M10.98M4.94M
Operating Income-1.90M-2.61M-5.52M-4.21M-3.28M-1.67M278.46K1.80M
Operating Margin-490.44%-300.82%-238.27%-102.45%-45.30%-12.85%1.51%7.53%
EBITDA-3.27K-3.25M-5.39M-4.65M-3.15M-1.58M143.57K2.15M
EBITDA Margin-0.85%-375.19%-232.29%-113.00%-43.60%-12.13%0.78%9.00%
Net Income-2.01M-3.16M-5.38M-4.54M-3.08M-1.67M214.66K3.61M
Net Income Margin-520.43%-365.09%-232.10%-110.40%-42.55%-12.84%1.17%15.11%
R&D118.49K87.99K------
R&D as % of Total Revenue30.65%10.16%------
Interest Expense4.32K31.46K67.78K32.81K31.29K165.32K196.67K114.60K
Interest Expense % of Total Revenue1.12%3.63%2.92%0.80%0.43%1.27%1.07%0.48%

Balance Sheet

Currency: AUD2019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets1.82M1.95M11.09M8.25M7.56M8.28M11.97M15.72M
Total Liabilities610.84K997.11K920.00K1.73M3.97M5.37M7.29M6.34M
Total Equity1.20M949.54K10.17M6.53M3.59M2.90M4.68M9.38M
Cash480.30K473.50K9.20M5.49M2.26M2.87M2.75M3.55M
Total Debt42.28K504.53K81.00K467.05K1.15M1.30M3.07M2.97M
Net Debt-438.02K31.03K-9.12M-5.03M-1.12M-1.57M326.81K-583.20K

Cash Flow

Currency: AUD2019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow-2.13M-3.22M-2.39M-3.42M-3.50M-163.81K-2.82M1.63M
Investing Cash Flow-520.00K-179.89K-28.77K-99.34K-400.94K-21.61K-200.38K-488.71K
Financing Cash Flow3.13M3.37M2.58M8.40M665.21K793.17K2.90M-333.48K
Capital Expenditure520.00K179.89K67.77K128.19K400.94K21.61K37.14K204.38K
Free Cash Flow-2.65M-3.40M-2.46M-3.55M-3.90M-185.41K-2.86M1.42M
Dividends Paid---170.00K----
FCF to OCF124.39%105.59%102.83%103.75%111.47%113.19%101.32%87.44%
Dividend Paid to FCF----4.79%----

Earnings

Report DateAug 28, 2022Nov 30, 2022Feb 26, 2023Apr 19, 2023Aug 23, 2023Oct 2, 2023Feb 20, 2024Apr 18, 2024Aug 25, 2024Oct 1, 2024Feb 17, 2025Apr 2, 2025Aug 26, 2025Dec 3, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.00
EPS Actual0.000.00-0.010.000.000.000.000.000.000.000.000.000.000.00
Surprise--------------
TimingAfter-hours---After-hours---After-hours-After-hours---

Key Statistics & Ratios

Market Cap97.19M
Enterprise Value90.62M
Trailing P/E21.00
Forward P/E0.00
Price / Sales4.07
Price / Book9.72
EPS0.02
Book Value0.041
Revenue (TTM)23.88M
Gross Profit (TTM)13.72M
EBITDA735.15K
Profit Margin15.11%
Operating Margin-0.44%
Return on Equity51.34%
Return on Assets2.63%
Shares Outstanding231.41M
Shares Float150.72M
Beta0.99
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%